New appointment at Third Rock Ventures
This article was originally published in Scrip
Third Rock Ventures, a US-based venture capital firm focused on launching life sciences companies, has appointed Dr Steven Paul venture partner. He leads the Helen & Robert Appel Institute for Alzheimer's Research at Weill Cornell Medical College and is the former president of the Lilly Research Laboratories. In his role as venture partner, Dr Paul will serve as a senior advisor to Third Rock and will participate in the development of potential new companies.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.